Gala­pa­gos paus­es blood can­cer CAR-T ther­a­py tri­al due to one Parkin­son­ism event

Gala­pa­gos has tem­porar­i­ly stopped en­rolling pa­tients in­to an ear­ly-phase test in pa­tients with mul­ti­ple myelo­ma af­ter a neu­ro­log­i­cal is­sue was raised. Else­where, the biotech ex­pand­ed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER